[Microbiological evaluation of the abacillary state in the combined therapy of destructive pulmonary tuberculosis in experimental animals].
D010131:Aminosalicylic Acid / Q000008:administration & dosage; D000818:Animals; D004285:Dogs; D004359:Drug Therapy, Combination; D007538:Isoniazid / Q000008:administration & dosage; D008168:Lung / Q000382:microbiology; D008198:Lymph Nodes / Q000382:microbiology; D012293:Rifampin / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000382:microbiology*
D010131:Aminosalicylic Acid; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Mikrobiilogicheskaia otsenka abatsillirovaniia pri kompleksnoĭ terapii destruktivnogo tuberkuleza legkikh u éksperimental'nykh zhivotnykh.